Therapietrouwbevordering lipidenverlagers is kosteneffectief: Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie

Stefan Vegter; Piter Oosterhof; Job F. M. Van Boven; Ada G. G. Stuurman-Bieze; Eric Hiddink; Maarten J. Postma

Cost-effectiveness in primary prevention, cost savings in secondary prevention: Promoting therapy adherence to antilipemic agents is cost effective: Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie

Stefan Vegter, Piter Oosterhof, Job F. M. Van Boven, Ada G. G. Stuurman-Bieze, Eric Hiddink, Maarten J. Postma

Microbes in Health and Disease (MHD)

Research output: Contribution to journal › Article › Professional

Translated title of the contribution	Cost-effectiveness in primary prevention, cost savings in secondary prevention: Promoting therapy adherence to antilipemic agents is cost effective
Original language	Dutch
Pages (from-to)	30-31
Number of pages	2
Journal	Pharmaceutisch Weekblad
Volume	149
Issue number	35
Publication status	Published - 29-Aug-2014

Keywords

antilipemic agent
cost control
cost effectiveness analysis
human
patient compliance
primary prevention
secondary prevention
short survey

Cite this

@article{8412c874c65a4a7fb4895cfda8671d36,

title = "Therapietrouwbevordering lipidenverlagers is kosteneffectief: Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie",

keywords = "antilipemic agent, cost control, cost effectiveness analysis, human, patient compliance, primary prevention, secondary prevention, short survey",

author = "Stefan Vegter and Piter Oosterhof and {Van Boven}, {Job F. M.} and Stuurman-Bieze, {Ada G. G.} and Eric Hiddink and Postma, {Maarten J.}",

year = "2014",

month = aug,

day = "29",

language = "Dutch",

volume = "149",

pages = "30--31",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "35",

}

Therapietrouwbevordering lipidenverlagers is kosteneffectief : Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie. / Vegter, Stefan; Oosterhof, Piter; Van Boven, Job F. M.; Stuurman-Bieze, Ada G. G.; Hiddink, Eric; Postma, Maarten J.

In: Pharmaceutisch Weekblad, Vol. 149, No. 35, 29.08.2014, p. 30-31.

Research output: Contribution to journal › Article › Professional

TY - JOUR

T1 - Therapietrouwbevordering lipidenverlagers is kosteneffectief

T2 - Kosteneffectiviteit bij primaire, kostenbesparing bij secundaire preventie

AU - Vegter, Stefan

AU - Oosterhof, Piter

AU - Van Boven, Job F. M.

AU - Stuurman-Bieze, Ada G. G.

AU - Hiddink, Eric

AU - Postma, Maarten J.

PY - 2014/8/29

Y1 - 2014/8/29

KW - antilipemic agent

KW - cost control

KW - cost effectiveness analysis

KW - human

KW - patient compliance

KW - primary prevention

KW - secondary prevention

KW - short survey

M3 - Article

VL - 149

SP - 30

EP - 31

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

SN - 0031-6911

IS - 35

ER -